publication date: Feb. 17, 2012
ODAC Votes to Nix Amgen’s Drug Xgeva for Proposed Prostate Cancer Indication Appropriations 2013: Obama Proposes Flat Funding for NIH Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials Download PDF
To access this members-only content, please log in.
Institutional subscribers, please log in with your IP
If you're not a subscriber why not join today?
To gain access to the members only content click here
You will be given immediate access to premium content on the site.Click here to join.